Gel4Med Revenue and Competitors
Estimated Revenue & Valuation
- Gel4Med's estimated annual revenue is currently $2.6M per year.
- Gel4Med's estimated revenue per employee is $155,000
Employee Data
- Gel4Med has 17 Employees.
- Gel4Med grew their employee count by 6% last year.
Gel4Med's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Senior Product Development Manager | Reveal Email/Phone |
3 | Manager, Business Development | Reveal Email/Phone |
4 | Post Doctoral Fellow (Biomaterials Scientist) | Reveal Email/Phone |
5 | Regulatory and Quality Assurance Associate | Reveal Email/Phone |
6 | Scientist - Cell and Tissue Biology | Reveal Email/Phone |
7 | Research And Development Associate | Reveal Email/Phone |
Gel4Med Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Gel4Med?
Gel4Med is an early stage regenerative medicine company focused on developing our Therapeutic Materials Platform to address unmet clinical needs in soft tissue regeneration. Our lead product is a synthetic tissue scaffolding matrix intended to eliminate colonizing antibiotic resistant bacteria from wounds (cutaneous, surgical, combat and ocular) and simultaneously promote tissue regeneration in a safe manner, without the use of exogenous added antibiotics or biologics.
keywords:N/AN/A
Total Funding
17
Number of Employees
$2.6M
Revenue (est)
6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $3.5M | 21 | 5% | N/A |
#2 | $3.5M | 21 | -12% | N/A |
#3 | $5.8M | 23 | -18% | N/A |
#4 | $5.3M | 44 | 7% | N/A |
#5 | $12.2M | 54 | 13% | N/A |